Pain Management Therapy

Project Number:
Marineo-01-07
Patent Numbers:
US Patent Pending
European Union Medical Device CE approval as an electronic-analgesic apparatus
Inventor:
The technology is from the research of Professor Giuseppe Marineo, a researcher and bioengineer, and the founder and manager of Delta Research & Development. Delta R&D, formed in May 1998, is a Medical Bioengineering Research Centre affiliated with Tor Vergata University of Rome in Italy.
Description:
The pain management therapy technology is a non-invasive method for rapid treatment of high-intensity oncologic, neuropathic, and drug-resistant pain through a biophysical rather than a biochemical manner. The method incorporates electromedical equipment for electronic nerve stimulation, and uses the nerve fiber as a passive means to convey a message of normality to the central nervous system (CNS) by a procedure defined as scrambling or mixing of information, which then enables the CNS to modify the reflex adaptive responses. Over 2,300 patients have been treated with the device in hospitals in Italy.
Advantages:
The non-invasive MC-5A device, using Scrambler technology, is a multiprocessor apparatus able to simultaneously treat multiple pain areas in the individual. Application is by means of single-use surface electrodes applied to the skin area corresponding to the pain area(s) involved.
Applications:
The global pain management market is estimated to reach $40 billion by 2010. Potential market opportunities include hospitals, nursing homes and hospices, cancer treatment centers, and pain management centers.

CTT has granted Excel Life Sciences, Inc. exclusive distribution rights in India for the device.

For more information please contact:

Aris D. Despo
Executive Vice President, Business Development
This email address is protected, Javascript must be enabled to view it
Tel: 704.519.5443